Scarica l'app Stockscreener
60.73
3.66%
-2.31
Dopo l'orario di chiusura:
61.51
0.78
+1.28%
Metsera Inc Borsa (MTSR) Ultime notizie
Key facts: Novo Nordisk Q3 revenue up 9.4%; bids $8.5B for Metsera; Hims launches semaglutide - TradingView
Why Pfizer Can Still Prevail in the Obesity Fight With Novo NordiskWSJ - The Wall Street Journal
Pfizer accuses Novo Nordisk of anticompetitive plot to stall Metsera deal in lawsuit - Reuters
Pfizer’s And Novo’s Competing Bids For Metsera Devolve Into Lawsuits, Name Calling - Citeline News & Insights
ACQUISITIONS & MERGERS NEWS: Pfizer sues Metsera and Novo Nordisk to halt their proposed merger - VitalLaw.com
Pfizer, Novo's Metsera war could redraw the map for obesity treatments - Axios
Pfizer Hits Novo Nordisk In Fed. Court Over $9B Metsera Deal - Law360
Metsera, Inc. Responds to Pfizer’s Litigation Claims - MSN
Metsera Calls Pfizer's Claims 'Nonsense' In Latest Buyout Battle Salvo - Investor's Business Daily
Pfizer Sues Novo, Metsera for Second Time in Brewing Deal War - Bloomberg.com
Pfizer Lawsuits Allege Novo Nordisk’s Bid to Buy Obesity Biotech Metsera is Anticompetitive, Illegal - MedCity News
Market Voices: Pfizer-Novo Nordisk legal battle; Trump on Zhao pardon - MSN
Pfizer Files Lawsuits Against Metsera and Novo Nordisk - Pharmaceutical Executive
Coinbase Said Web3 - Bloomberg.com
Pfizer sues to block Novo Nordisk bid for obesity drug maker Metsera - The Business Journals
Pfizer files US court challenge to Novo's bid for Metsera - MLex
FinCEN Offers Relief to Banks on ‘Overwhelming’ SARs Filings - PYMNTS.com
Pfizer files second lawsuit against Metsera, Novo Nordisk - whbl.com
Novo Nordisk’s Attempt to Buy Metsera is Anticompetitive, Says Pfizer in Second Lawsuit - TipRanks
Pfizer Q3 Earnings Preview: Results to test recovery hopes amid TrumpRx deal, Metsera dispute - MSN
Metsera rejects Pfizer litigation as attempt to lower acquisition price - Investing.com
Pfizer sues Novo, Metsera for second time in brewing deal war - Crain's New York Business
Metsera issues statement regarding Pfizer litigation and proposed acquisition By Investing.com - Investing.com UK
Metsera issues statement regarding Pfizer litigation and proposed acquisition - Investing.com
Novo Nordisk says Metsera bid won’t raise antitrust issues By Reuters - Investing.com
Pfizer Q3 Earnings Preview: Results to test recovery hopes amid TrumpRx deal, Metsera dispute (PFE:NYSE) - Seeking Alpha
Novo Nordisk says Metsera bid won't raise antitrust issues - Reuters
Pfizer Files Antitrust Suit to Block Novo Nordisk Acquisition of Metsera - The Wall Street Journal
Pfizer Aligns With Trump on Drug Pricing In Its Bid for Biotech Metsera - Barron's
Novo Nordisk spokesperson says Pfizer's claims against co's Metsera offer is "without merit" - MarketScreener
Another Pfizer lawsuit to stop Novo bid for Metsera - The Pharma Letter
Pfizer files second lawsuit against Novo Nordisk, Metsera in bidding war over obesity biotech - CNBC
Pfizer Files Antitrust Lawsuit Against Metsera, Its Controlling Stockholders And Novo Nordisk - Nasdaq
Metsera Responds to Pfizer's Legal Action Amid Bid Interest from Novo Nordisk (NVO) - GuruFocus
Metsera to address Pfizer's litigation in court - MarketScreener
Metsera Issues Statement in Response to Litigation - Yahoo Finance
UPDATE: Pfizer Files Lawsuits Against Novo Nordisk, Metsera To Stop Rival Bid - BioSpace
How to build a custom watchlist for Metsera Inc.Market Growth Summary & Weekly Setup with High ROI Potential - newser.com
Is Metsera Inc. stock entering bullish territory2025 Dividend Review & Community Supported Trade Ideas - newser.com
Pfizer files two lawsuits to stop Novo's $9B buyout of Metsera - BioWorld MedTech
Is Metsera Inc. stock a safe investment in uncertain marketsTrade Entry Summary & Reliable Trade Execution Plans - newser.com
Pfizer files another lawsuit: Accuses Metsera owners of conspiring with Novo Nordisk - medwatch.com
Metsera falls after Pfizer files a second lawsuit against co and Novo - TradingView
How currency fluctuations impact Metsera Inc. stockJuly 2025 Summary & Proven Capital Preservation Tips - newser.com
Pfizer (PFE) Files Lawsuit Against Novo Nordisk Over Metsera Bid - GuruFocus
Pfizer Accuses Novo Nordisk Of Antitrust Violations In Metsera Takeover Battle - Benzinga
The Battle For Metsera Acquisition Heats Up As Pfizer Files A Second Lawsuit - MSN
Pfizer files second lawsuit to block Novo Nordisk’s $9bn Metsera bid - Financial Times
Pfizer files second lawsuit against Novo Nordisk, Metsera in battle over obesity startup - statnews.com
Pfizer sues Novo Nordisk and Metsera once againbid considered to restrict competition - MarketScreener
Why Metsera Inc. stock appeals to analystsEntry Point & Advanced Technical Signal Analysis - newser.com
Pfizer files second lawsuit in fight over Metsera - Axios
Pfizer files second lawsuit against Metsera, Novo Nordisk By Reuters - Investing.com
Pfizer files fresh US lawsuit against Novo Nordisk bid for Metsera - MLex
Pfizer Files Federal Antitrust Claims in Second Lawsuit Against Metsera, its Controlling Stockholders and Novo Nordisk - The Globe and Mail
Pfizer escalates fight over Metsera with second lawsuit - FirstWord Pharma
Pfizer hits Novo Nordisk and Metsera with lawsuit amid bidding war - Yahoo Finance
Pfizer Gains Early FTC Clearance for Metsera Acquisition - Zacks Investment Research
0.64%
0.35%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):